Literature DB >> 8887575

Toluene diisocyanate-induced in vitro tracheal hyperreactivity in the mouse.

H Scheerens1, T L Buckley, E M Davidse, J Garssen, F P Nijkamp, H Van Loveren.   

Abstract

Toluene diisocyantate (TDI) is a low-molecular-weight compound that is known to cause occupational asthma in 5% to 10% of exposed workers. These patients exhibit marked airway hyperresponsiveness and granulocyte accumulation in the airways, and 10% to 20% were also determined to have TDI-specific IgE in their serum. In this study, we developed a murine model for TDI-induced asthma. After several sensitization and challenge regimens were tested, it was decided that optimal sensitization was observed after mice (BALB/c) were skin sensitized with TDI (1%) two times on two consecutive days and challenged intranasally 8 d later with TDI (1%). Sensitized mice exhibited tracheal hyperreactivity to carbachol 24 h after challenge (69% increase in maximal contractile response). In contrast, no differences between the control and TDI-treated groups was observed 2 and 48 h after challenge with 1% TDI. There appeared to be no elevation in TDI-specific IgE antibodies in the serum at all time points measured. In addition, no influx of leukocytes could be detected histologically in the trachea and lung tissue or airway lumen 2, 24, and 48 h after the challenge. Surprisingly, the tracheal hyperreactivity was associated with a marked increase in myeloperoxidase but not eosinophil peroxidase activity in the lung tissue and in the cells of the bronchoalveolar lavage fluid at 24 h after the challenge. To investigate the role of lymphocytes in the induction of tracheal hyperreactivity, mice were passively sensitized by intravenous injection of lymphoid cells from TDI-sensitized donor mice. Similar to active sensitization, adoptive transfer of lymphocytes from sensitized donors resulted in tracheal hyperreactivity 24 h after challenge of the recipients. In conclusion, these data show that TDI is capable of inducing lymphocyte-dependent but IgE-independent tracheal hyperreactivity in the mouse that is not associated with cellular infiltration in the airways. This model can be used to further investigate the possible mechanisms involved in the development of occupational asthma induced by TDl.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887575     DOI: 10.1164/ajrccm.154.4.8887575

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  5 in total

1.  Health information in material safety data sheets for a chemical which causes asthma.

Authors:  L M Frazier; B W Beasley; G K Sharma; A A Mohyuddin
Journal:  J Gen Intern Med       Date:  2001-02       Impact factor: 5.128

2.  The involvement of sensory neuropeptides in toluene diisocyanate-induced tracheal hyperreactivity in the mouse airways.

Authors:  H Scheerens; T L Buckley; T Muis; H Van Loveren; F P Nijkamp
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

3.  Murine model for non-IgE-mediated asthma.

Authors:  Hanneke P M van der Kleij; Aletta D Kraneveld; Anneke H van Houwelingen; Mirjam Kool; Andrys C D Weitenberg; Frank A M Redegeld; Frans P Nijkamp
Journal:  Inflammation       Date:  2004-06       Impact factor: 4.092

4.  Hypersensitivity reactions in mouse airways after a single and a repeated hapten challenge.

Authors:  A H van Houwelingen; S C A de Jager; M Kool; D van Heuven-Nolsen; A D Kraneveld; F P Nijkamp
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

5.  Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.

Authors:  Andy Forreryd; Henrik Johansson; Ann-Sofie Albrekt; Carl A K Borrebaeck; Malin Lindstedt
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.